published on: may 17, 2018 | last updated: may 17, 2018 5:42 pm pdt
.
.
.
loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people.
.
yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital.
https://grassfed.us/Simler-daughter-of-Bialy-from-Burnaby